Breaking News

Close

BioCryst Pharmaceuticals Inc (BCRX)

	Symbol	Exchange	Currency
	BCRX	NASDAQ	USD	Real-time
	BCRX	TradeGate	EUR	Delayed

Add to/Remove from Watchlist Add to Watchlist

6.460 -0.110 -1.67%

31/05 - Closed. Currency in USD ( Disclaimer )

After Hours

6.470

+0.010

+0.155%

18:51:39 - Real-time Data

Type: Equity

Market: United States

Volume: 3,828,855
Bid/Ask: 0.000 / 0.000
Day's Range: 6.430 - 6.815

NASDAQ:BCRX Financials

A brief overview of the NASDAQ:BCRX financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of BioCryst over time.

BioCryst Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported revenue was USD 92.76 million compared to USD 68.78 million a year ago. Net loss was USD 35.38 million compared to USD 53.33 million a year ago. Basic loss per share from continuing operations was USD 0.17 compared to USD 0.28 a year ago. Diluted loss per share from continuing operations was USD 0.17 compared to USD 0.28 a year ago.

Annual Quarterly

Advanced Financial Summary

TTM = Trailing Twelve Months

MRQ = Most Recent Quarter

BCRX Income Statement

Gross margin TTM 39.44%

Operating margin TTM -23.88%

Net Profit margin TTM -58.69%

Return on Investment TTM 0%

Total Revenue Net Income

Period Ending:	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023
Total Revenue	92.76	93.4	86.74	82.49
Gross Profit	44.88	26.29	38.73	30.29
Operating Income	-14.49	-37.74	-11.92	-20.7
Net Income	-35.38	-61.73	-36.15	-75.33

BCRX Balance Sheet

Quick Ratio MRQ 3.31

Current Ratio MRQ 3.73

LT Debt to Equity MRQ 0%

Total Debt to Equity MRQ -179.12%

Total Assets Total Liabilities

Period Ending:	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023
Total Assets	467.89	516.96	522.92	529.88
Total Liabilities	944.06	972.49	933.91	918.6
Total Equity	-476.17	-455.53	-410.99	-388.71

BCRX Cash Flow Statement

Cash Flow/Share TTM -0.49

Revenue/Share TTM 1.72

Operating Cash Flow -44.76%

Cash Net Change in Cash

Period Ending:	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023
Period Length:	0 Months	0 Months	0 Months	0 Months
Cash From Operating Activities	-53.68	-8.92	-19.9	-18.81
Cash From Investing Activities	28.76	-28.47	23.12	-19.04
Cash From Financing Activities	-1.05	-3.17	1.22	29.36
Net Change in Cash	-26.32	-40.04	4.7	-8.81

* In Millions of USD (except for per share items)

InvestingPro

Go to Dashboard InvestingPro

InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

BCRX Comments

Write your thoughts about BioCryst Pharmaceuticals Inc

Are you sure you want to delete this chart?

Post also to:

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Frank Tofini May 28, 2024 12:01PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

I think the insiders bought in heavily because the CDC is requesting a few million doses of Peramivir to be prepared for the possible pandemic.

0 0

Jean Mercredi May 06, 2024 10:02AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Strong

0 0

Jean Mercredi Jan 09, 2023 10:05AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

What happened?

0 0

Jean Mercredi Oct 04, 2022 10:45AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Back on track

0 0

Giuseppe Giannachi Apr 08, 2022 1:41PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

This hammering looks a little too severe.

0 0

Kainee Foo Apr 08, 2022 11:24AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

what's wrong?

0 1

Giuseppe Giannachi Apr 08, 2022 11:24AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Clinical trial product halt.

0 0

Giuseppe Giannachi Apr 08, 2022 9:57AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Man...

1 1

Edwin Henriquez Feb 23, 2022 9:02AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

what a joke with earnings worse in years and with FDA approval seriously

0 0

Edwin Henriquez Jan 10, 2022 2:01PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

The Food and Drug Administration (FDA) approved BioCryst's first drug, Orladeyo, a little over a year ago. The first few quarters post-launch for the drug, which prevents attacks of hereditary angioedema, were less than inspiring. But preliminary fourth-quarter figures released today suggest the drug really can achieve more than $1 billion in annual sales.

5 3

Jean Mercredi Jan 10, 2022 11:19AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Why up so much?

0 0

Edwin Henriquez Jan 10, 2022 11:19AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

preliminary earnings is looking super good 👌

2 0

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="218673265">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="218673265" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="218673265" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="218673265">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="212704543">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="212704543" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="212704543" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="212704543">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
		</div>
    </div>
			</div>
			<div id="show-more-comments">
				<a class="showMoreComments block">
					<span class="arial_12 showArrowafter">Show more comments (<span class="js-amount"></span>)</span>
				</a>
			</div>
			<div id="show-more-replies">
				<a class="showMoreReplies block">
					<span class="arial_12 showArrowafter">Show more replies (<span class="js-amount"></span>)</span>
				</a>
			</div>

Are you sure you want to delete this chart?

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

	US 30	38,742.2	+630.7	+1.65%
	US 500	5,285.4	+49.9	+0.95%
	Dow Jones	38,686.32	+574.84	+1.51%
	S&P 500	5,277.51	+42.03	+0.80%
	Nasdaq	16,735.02	-2.06	-0.01%
	S&P 500 VIX	12.92	-1.55	-10.71%
	Dollar Index	104.575	-0.083	-0.08%

	Crude Oil WTI	77.18	-0.73	-0.94%
	Brent Oil	81.37	-0.51	-0.62%
	Natural Gas	2.581	+0.009	+0.35%
	Gold	2,347.70	-18.80	-0.79%
	Silver	30.555	-0.979	-3.10%
	Copper	4.6275	-0.0310	-0.67%
	US Soybeans	1,205.00	-4.75	-0.39%

	U.S. 10Y	4.503	-0.009	-0.21%
	U.S. 30Y	4.650	-0.002	-0.04%
	U.S. 5Y	4.509	-0.019	-0.43%
	U.S. 3M	5.409	+0.018	+0.33%
	US 10Y T-Note	108.48	+0.25	+0.23%
	Euro Bund	129.29	+0.03	+0.02%
	10-2 Yield Spread	-37.89	-1.79	4.96%

	Apple	192.25	+1.03	+0.54%
	Alphabet A	172.50	+0.40	+0.23%
	Tesla	178.08	-0.69	-0.39%
	Amazon.com	176.44	-2.88	-1.60%
	Netflix	641.62	-5.63	-0.87%
	Meta Platforms	466.83	+0.24	+0.05%
	Bank of America	39.99	+1.36	+3.52%

Recent Quotes

	Name	Price	Chg.	Chg. %
	BCRX	6.460	-0.110	-1.67%

	Name	Last	Chg. %	Vol.
	AAPL	192.25	+0.54%	75.00M
	TSLA	178.08	-0.39%	67.17M
	DELL	139.56	-17.87%	67.05M
	AMD	166.90	+0.16%	64.05M
	NVDA	1,096.33	-0.82%	61.04M
	MSFT	415.13	+0.23%	28.56M
	AVGO	1,328.55	-2.45%	7.18M

	Name	Last	Chg. %	Vol.
	CZR	35.56	+11.65%	26.49M
	ZS	169.96	+8.50%	10.09M
	VFC	13.28	+7.66%	21.24M
	CRM	234.44	+7.54%	36.74M
	DG	136.94	+7.03%	3.76M
	CVS	59.60	+6.35%	22.33M
	ELV	538.48	+6.14%	3.88M

	Name	Last	Chg. %	Vol.
	MDB	236.06	-23.85%	10.98M
	MRVL	68.81	-10.43%	37.07M
	PAYC	145.32	-8.57%	2.02M
	DDOG	110.18	-6.19%	10.48M
	MRNA	142.55	-5.89%	7.17M
	SMCI	784.51	-5.25%	7.29M
	HPQ	36.50	-4.85%	29.93M

Smart Position Sizing Strategies for Superior Trading Performance Wednesday, June 5, 2024 | 08:00AM EDT